715 related articles for article (PubMed ID: 33989516)
1. The SARS-CoV-2 RNA interactome.
Lee S; Lee YS; Choi Y; Son A; Park Y; Lee KM; Kim J; Kim JS; Kim VN
Mol Cell; 2021 Jul; 81(13):2838-2850.e6. PubMed ID: 33989516
[TBL] [Abstract][Full Text] [Related]
2. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
Davies JP; Almasy KM; McDonald EF; Plate L
ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
[TBL] [Abstract][Full Text] [Related]
3. The SARS-CoV-2 RNA-protein interactome in infected human cells.
Schmidt N; Lareau CA; Keshishian H; Ganskih S; Schneider C; Hennig T; Melanson R; Werner S; Wei Y; Zimmer M; Ade J; Kirschner L; Zielinski S; Dölken L; Lander ES; Caliskan N; Fischer U; Vogel J; Carr SA; Bodem J; Munschauer M
Nat Microbiol; 2021 Mar; 6(3):339-353. PubMed ID: 33349665
[TBL] [Abstract][Full Text] [Related]
4. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.
Kamel W; Noerenberg M; Cerikan B; Chen H; Järvelin AI; Kammoun M; Lee JY; Shuai N; Garcia-Moreno M; Andrejeva A; Deery MJ; Johnson N; Neufeldt CJ; Cortese M; Knight ML; Lilley KS; Martinez J; Davis I; Bartenschlager R; Mohammed S; Castello A
Mol Cell; 2021 Jul; 81(13):2851-2867.e7. PubMed ID: 34118193
[TBL] [Abstract][Full Text] [Related]
5. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.
Labeau A; Fery-Simonian L; Lefevre-Utile A; Pourcelot M; Bonnet-Madin L; Soumelis V; Lotteau V; Vidalain PO; Amara A; Meertens L
Cell Rep; 2022 Apr; 39(4):110744. PubMed ID: 35477000
[TBL] [Abstract][Full Text] [Related]
6. Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs.
Almasy KM; Davies JP; Plate L
Mol Cell Proteomics; 2021; 20():100120. PubMed ID: 34186245
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.
Jiang L; Xiao M; Liao QQ; Zheng L; Li C; Liu Y; Yang B; Ren A; Jiang C; Feng XH
mSystems; 2023 Aug; 8(4):e0013523. PubMed ID: 37314180
[TBL] [Abstract][Full Text] [Related]
8. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
[TBL] [Abstract][Full Text] [Related]
9. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
J Virol; 2021 May; 95(12):. PubMed ID: 33789998
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.
Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452305
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.
Ferrarini MG; Lal A; Rebollo R; Gruber AJ; Guarracino A; Gonzalez IM; Floyd T; de Oliveira DS; Shanklin J; Beausoleil E; Pusa T; Pickett BE; Aguiar-Pulido V
Commun Biol; 2021 May; 4(1):590. PubMed ID: 34002013
[TBL] [Abstract][Full Text] [Related]
12. Targeting the m
Burgess HM; Depledge DP; Thompson L; Srinivas KP; Grande RC; Vink EI; Abebe JS; Blackaby WP; Hendrick A; Albertella MR; Kouzarides T; Stapleford KA; Wilson AC; Mohr I
Genes Dev; 2021 Jul; 35(13-14):1005-1019. PubMed ID: 34168039
[TBL] [Abstract][Full Text] [Related]
13. The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP.
Afrasiabi A; Alinejad-Rokny H; Khosh A; Rahnama M; Lovell N; Xu Z; Ebrahimi D
Sci Rep; 2022 Feb; 12(1):2420. PubMed ID: 35165300
[TBL] [Abstract][Full Text] [Related]
14. TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein.
Zheng X; Wang X; Tu F; Wang Q; Fan Z; Gao G
J Virol; 2017 May; 91(9):. PubMed ID: 28202764
[TBL] [Abstract][Full Text] [Related]
15. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
Kaur R; Tada T; Landau NR
mBio; 2023 Aug; 14(4):e0109023. PubMed ID: 37382452
[TBL] [Abstract][Full Text] [Related]
16. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
Hoffmann HH; Sánchez-Rivera FJ; Schneider WM; Luna JM; Soto-Feliciano YM; Ashbrook AW; Le Pen J; Leal AA; Ricardo-Lax I; Michailidis E; Hao Y; Stenzel AF; Peace A; Zuber J; Allis CD; Lowe SW; MacDonald MR; Poirier JT; Rice CM
Cell Host Microbe; 2021 Feb; 29(2):267-280.e5. PubMed ID: 33357464
[TBL] [Abstract][Full Text] [Related]
17. Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation.
Meyerson NR; Zhou L; Guo YR; Zhao C; Tao YJ; Krug RM; Sawyer SL
Cell Host Microbe; 2017 Nov; 22(5):627-638.e7. PubMed ID: 29107643
[TBL] [Abstract][Full Text] [Related]
18. TRIM6 facilitates SARS-CoV-2 proliferation by catalyzing the K29-typed ubiquitination of NP to enhance the ability to bind viral genomes.
Zhou J; Zhou Y; Wei XF; Fan L; Gao X; Li Y; Wu Y; Feng W; Shen X; Liu L; Xu G; Zhang Z
J Med Virol; 2024 Mar; 96(3):e29531. PubMed ID: 38515377
[TBL] [Abstract][Full Text] [Related]
19. Host PDZ-containing proteins targeted by SARS-CoV-2.
Caillet-Saguy C; Durbesson F; Rezelj VV; Gogl G; Tran QD; Twizere JC; Vignuzzi M; Vincentelli R; Wolff N
FEBS J; 2021 Sep; 288(17):5148-5162. PubMed ID: 33864728
[TBL] [Abstract][Full Text] [Related]
20. Detection of A-to-I RNA Editing in SARS-COV-2.
Picardi E; Mansi L; Pesole G
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
